Thermo Fisher Scientific
Provisioner of scientific consumables
Follow Thermo Fisher Scientific on Notably News to receive short updates to your email — rarely!
| November 2023 | Established a partnership with Flagship Pioneering to create new companies in the biotechnology field. |
| July 2023 | The court ordered the parties to attend a settlement conference regarding the HeLa cells lawsuit. A settlement with undisclosed terms was subsequently announced. |
| May 2023 | Partnered with Pfizer to expand testing capabilities for lung and breast cancer patients. |
| 2022 | Halted sales of DNA collection kits in Tibet after the Inter-Parliamentary Alliance on China called for investigating the company's commercial activities related to biometric surveillance. |
| May 2022 | Thermo Fisher Scientific went to court seeking dismissal of the lawsuit filed by Henrietta Lacks' estate regarding the unauthorized use of her cells. |
| February 2022 | Announced a 15-year strategic collaboration agreement with Moderna, Inc. to scale up manufacturing of Moderna's COVID-19 vaccine and other investigational mRNA products. |
| 2021 | Announced the construction of a cell therapy development, manufacturing, and collaboration center in partnership with University of California, San Francisco on the Mission Bay campus. |
| 2021 | Acquired PPD (Pharmaceutical Product Development), a global contract research organization, expanding its clinical development solutions. |
| October 2021 | The estate of Henrietta Lacks filed a lawsuit against Thermo Fisher Scientific for the unauthorized sale of HeLa cells, which have been used in over 60,000 scientific studies and involved over 50 million tons of cell production. |
| June 2021 | The New York Times reported that Thermo Fisher Scientific continued selling equipment to police in Xinjiang despite previous bans. |
| August 2020 | Thermo Fisher Scientific opened a new Lenexa facility to boost production and manufacturing of COVID-19 testing supplies. |
| June 2020 | Reported to have sold equipment to Chinese security services for use in a genetic surveillance program targeting ethnic minorities. |
| March 2020 | Thermo Fisher Scientific received FDA emergency use authorization for a SARS-CoV-2 test to help mitigate the COVID-19 pandemic. |
| February 2019 | Thermo Fisher Scientific announced it would stop selling equipment in Xinjiang, responding to concerns about potential misuse of their technology in ethnic surveillance. |
| 2018 | Acquired BD Advanced Bioprocessing, further strengthening its bioprocessing capabilities. |
| September 2017 | Signed an agreement with the Institute of Pathology Heidelberg (IPH) to establish a Center of Molecular Pathology at Heidelberg University Hospital, joining the Next Generation Sequencing Companion Dx Center of Excellence Program to support precision oncology research in Europe. |
| 2016 | Acquired two significant companies: Affymetrix (a biotechnology company) and FEI Company (a manufacturer of electron microscopes and scientific instruments). |
| 2015 | Purchased Alfa Aesar, a global supplier of research chemicals and materials. |
| 2013 | Acquired Life Technologies Corporation, expanding its portfolio of scientific research and diagnostic technologies. |
This contents of the box above is based on material from the Wikipedia article Thermo Fisher Scientific, which is released under the Creative Commons Attribution-ShareAlike 4.0 International License.